Epitope specificity and IgG subclass distribution of autoantibodies to cardiac troponin

Clinical Chemistry

Volumn 59, Issue 3, 2013, Pages 512-518

  Savukoski, Tanja ^a   Twarda, Aleksandra ^a   Hellberg, Sanna ^a   Ristiniemi, Noora ^a   Wittfooth, Saara ^a   Sinisalo, Juha ^b   Pettersson, Kim ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; EPITOPE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3 ANTIBODY; IMMUNOGLOBULIN G4; TROPONIN I;

AMINO TERMINAL SEQUENCE; ANTIBODY COMBINING SITE; ANTIBODY SPECIFICITY; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; ENZYME IMMUNOASSAY; FOLLOW UP; HUMAN; HUMAN TISSUE; NORMAL HUMAN; PREVALENCE; THORAX PAIN;

ANTIBODY SPECIFICITY; AUTOANTIBODIES; EPITOPES; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; TROPONIN I;

EID: 84874599026     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2012.194860     Document Type: Article

References (27)

1. Thygesen K, Alpert JS, White HD, Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 2007;28:2525-38.
2. Panteghini M, Gerhardt W, Apple FS, Dati F, Ravkilde J, Wu AH. Quality specifications for cardiac troponin assays. Clin Chem Lab Med 2001; 39:175-9.
3. Tang G, Wu Y, Zhao W, Shen Q. Multiple immunoassay systems are negatively interfered by circulating cardiac troponin I autoantibodies. Clin Exp Med 2011;12:47-53.
4. Savukoski T, Engstrom E, Engblom J, Ristiniemi N, Wittfooth S, Lindahl B, et al. Troponin-specific autoantibody interference in different cardiac troponin I assay configurations. Clin Chem 2012;58: 1040-8.
5. Eriksson S, Junikka M, Laitinen P, Majamaa-Voltti K, Alfthan H, Pettersson K. Negative interference in cardiac troponin I immunoassays from a frequently occurring serum and plasma component. Clin Chem 2003;49:1095-104.
6. Shmilovich H, Danon A, Binah O, Roth A, Chen G, Wexler D, et al. Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy. Int J Cardiol 2007;117: 198-203.
7. Landsberger M, Staudt A, Choudhury S, Trimpert C, Herda LR, Klingel K, et al. Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy. Am Heart J 2008;156:92-9.
8. Adamczyk M, Brashear RJ, Mattingly PG. Circulating cardiac troponin-I autoantibodies in human plasma and serum. Ann N Y Acad Sci 2009;1173: 67-74.
9. Adamczyk M, Brashear RJ, Mattingly PG. Prevalence of autoantibodies to cardiac troponin T in healthy blood donors. Clin Chem 2009;55: 1592-3.
10. Pettersson K, Eriksson S, Wittfooth S, Engstrom E, Nieminen M, Sinisalo J. Autoantibodies to cardiac troponin associate with higher initial concentrations and longer release of troponin I in acute coronary syndrome patients. Clin Chem 2009;55: 938-45.
11. Okazaki T, Tanaka Y, Nishio R, Mitsuiye T, Mizoguchi A, Wang J, et al. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med 2003;9:1477-83.
12. Goser S, Andrassy M, Buss SJ, Leuschner F, Volz CH, Ottl R, et al. Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation 2006;114:1693-702.
13. Volz HC, Buss SJ, Li J, Goser S, Andrassy M, Ottl R, et al. Autoimmunity against cardiac troponin I in ischaemia reperfusion injury. Eur J Heart Fail 2011;13:1052-9.
14. Latva-Hirvela J, Kyto V, Saraste A, Eriksson S, Vuorinen T, Pettersson K, et al. Development of troponin autoantibodies in experimental coxsackievirus B3 myocarditis. Eur J Clin Invest 2009; 39:457-62.
15. Leuschner F, Li J, Goser S, Reinhardt L, Ottl R, Bride P, et al. Absence of auto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction. Eur Heart J 2008;29:1949-55.
16. Miettinen KH, Eriksson S, Magga J, Tuomainen P, Kuusisto J, Vanninen EJ, et al. Clinical significance of troponin I efflux and troponin autoantibodies in patients with dilated cardiomyopathy. J Card Fail 2008;14:481-8.
17. Doesch AO, Mueller S, Nelles M, Konstandin M, Celik S, Frankenstein L, et al. Impact of troponin I-autoantibodies in chronic dilated and ischemic cardiomyopathy. Basic Res Cardiol 2011;106: 25-35.
18. Dungen HD, Platzeck M, Vollert J, Searle J, Muller C, Reiche J, et al. Autoantibodies against cardiac troponin I in patients with congestive heart failure. Eur J Heart Fail 2010;12:668-75.
19. Lindahl B, Venge P, Eggers KM, Gedeborg R, Ristiniemi N, Wittfooth S, et al. Autoantibodies to cardiac troponin in acute coronary syndromes. Clin Chim Acta 2010;411:1793-8.
20. von Lode P, Rosenberg J, Pettersson K, Takalo H. A europium chelate for quantitative point-of-care immunoassays using direct surface measurement. Anal Chem 2003;75:3193-201.
21. Eriksson S, Halenius H, Pulkki K, Hellman J, Pettersson K. Negative interference in cardiac troponin I immunoassays by circulating troponin autoantibodies. Clin Chem 2005;51:839-47.
22. Sinisalo J, Mattila K, Valtonen V, Anttonen O, Juvonen J, Melin J, et al. Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-Q-wave coronary syndrome. Circulation 2002;105:1555-60.
23. Eriksson S, Junikka M, Pettersson K. An interfering component in cardiac troponin I immunoassays: its nature and inhibiting effect on the binding of antibodies against different epitopes. Clin Biochem 2004;37:472-80.
24. Nirula A, Glaser SM, Kalled SL, Taylor FR. What is IgG4? A review of the biology of a unique immunoglobulin subtype. Curr Opin Rheumatol 2011;23:119-24.
25. Aalberse RC, Stapel SO, Schuurman J, Rispens T. Immunoglobulin G4: an odd antibody. Clin Exp Allergy 2009;39:469-77.
26. Kawa S, Kitahara K, Hamano H, Ozaki Y, Arakura N, Yoshizawa K, et al. A novel immunoglobulinimmunoglobulin interaction in autoimmunity. PLoS One 2008;3:e1637.
27. Ito T, Kitahara K, Umemura T, Ota M, Shimozuru Y, Kawa S, et al. A novel heterophilic antibody interaction involves IgG4. Scand J Immunol 2010; 71:109-14.